ATAD2
Basic information
Region (hg38): 8:123319850-123416350
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (132 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATAD2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014109.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 126 | 133 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 126 | 7 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATAD2 | protein_coding | protein_coding | ENST00000287394 | 28 | 96501 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00180 | 125707 | 0 | 40 | 125747 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.66 | 589 | 714 | 0.825 | 0.0000370 | 9122 |
Missense in Polyphen | 83 | 179.63 | 0.46206 | 2188 | ||
Synonymous | -0.511 | 258 | 248 | 1.04 | 0.0000121 | 2587 |
Loss of Function | 6.68 | 13 | 75.8 | 0.172 | 0.00000482 | 908 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000459 | 0.000456 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000375 | 0.000231 |
European (Non-Finnish) | 0.000152 | 0.000149 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000270 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells. {ECO:0000269|PubMed:17998543}.;
- Pathway
- Gastric Cancer Network 2;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.100
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.75
Haploinsufficiency Scores
- pHI
- 0.424
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.678
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atad2
- Phenotype
Gene ontology
- Biological process
- chromatin organization;regulation of transcription by RNA polymerase II;negative regulation of chromatin silencing;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;extracellular exosome
- Molecular function
- chromatin binding;protein binding;ATP binding;ATPase activity;histone binding